Print full article

Feline parasite solution gets FDA approval

The combination formula from Merck contains fluralaner and moxidectin

Suggested Veterinary Products

Merck Animal Health has received U.S. Food and Drug Administration (FDA) approval for an extended-duration topical solution that protects cats from fleas, ticks, and other parasites.

Bravecto Plus is a combination formula comprised of fluralaner (280 mg/ml) and moxidectin (14 mg/ml), and can be used to treat both external and internal infestations. The formula offers feline patients two months’ protection with one application.

The product, says Christine Royal, DVM, Merck Animal Health’s director of professional services, addresses five feline parasite concerns: ticks, fleas, heartworms, roundworms, and hookworms.

“These parasites are not just a nuisance, but also pose animal and human health risks,” she says. “Ticks and fleas can transmit disease, and heartworm disease transmitted by mosquitoes is a serious, progressive disease that often goes undiagnosed in cats.”

The solution kills 100 percent of fleas and more than 99.7 percent of ticks within 12 hours of application, Merck says.

Leave a Comment



Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.